Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Scanning for amyloid

Amyloid is a brain protein which is associated with dementia, but it is difficult and expensive to detect. This team is conducting brain scans on 500 men and women who are already members of a long-term health study. Their extremely valuable data will be used to develop new, more convenient ways of testing for amyloid in the brain.

Studying the disease that runs in families

Some of the diseases that cause dementia have a genetic element. Looking at familial disease dementia is important because those genetically predisposed to dementia can be analysed for indicators that can then be used to improve our understanding of the other forms of the disease.

Looking for the biological signs of Alzheimer's disease

Uncovering the biological signs of change that are associated with the development of Alzheimer's disease is a crucial part of detecting it at its earliest stages and developing effective treatments.

Brain scanning at a new scale

Scanning 10,000 participants a few years after a baseline scan allows for very informative findings about how our brains change as they get older.

Profiling the data in existing health studies

This early area of work identified which long-term studies of health – known as 'cohorts' – would be particularly helpful for dementia research, and summarised their information for researchers’ use on the Data Portal.